Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Teva Pharmaceutical Industries Limited (TEVA)

9.01   0.16 (1.81%) 10-01 08:31
Open: 8.94 Pre. Close: 8.85
High: 9.1975 Low: 8.89
Volume: 7,653,088 Market Cap: 9,851M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.903 - 8.939 8.939 - 8.976
Low: 8.612 - 8.649 8.649 - 8.688
Close: 8.759 - 8.824 8.824 - 8.89

Technical analysis

as of: 2020-09-30 4:47:03 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 10.92     One year: 11.56
Support: Support1: 8.46    Support2: 7.04
Resistance: Resistance1: 9.35    Resistance2: 9.90
Pivot: 8.93
Moving Average: MA(5): 8.71     MA(20): 9.00
MA(100): 11.19     MA(250): 10.29
MACD: MACD(12,26): -0.40     Signal(9): -0.46
Stochastic oscillator: %K(14,3): 30.63     %D(3): 21.99
RSI: RSI(14): 37.87
52-week: High: 13.76  Low: 6.25  Change(%): 26.4
Average Vol(K): 3-Month: 875683  10-Days: 714201

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TEVA has closed above bottom band by 39.1%. Bollinger Bands are 52.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 01 Oct 2020
Bulk Drug Market 2026| Teva Active Pharmaceutical Industries Limited • Roche • Pfizer • Cambrex • Novartis • Johnson & Johnson; Post Pandemic Opportunities - The Daily Chronicle

Thu, 01 Oct 2020
Prescription Drugs Market 2026| Bristol-Myers Squibb Company • GlaxoSmithKline PLC • Boehringer Ingelheim GmbH • Teva Pharmaceutical Industries Ltd • F. Hoffmann-La Roche AG; Post Pandemic Opportunities - The Daily Chronicle

Wed, 30 Sep 2020
Comprehensive Report on Raloxifene Hydrochloride Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Teva Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc., Jiangsu Hengrui Medicine Co. Ltd., Sanika Chemical Pvt Ltd., Zydus Alidac - The Daily Chronicle

Wed, 30 Sep 2020
Parkinson's Disease Market is Outperforming | Global Players - Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Acorda Therapeutics - The Market Records

Wed, 30 Sep 2020
Caspofungin Market Segmentation, Proposal Strategy, Share and Growth|Teva Pharmaceutical Industries - PharmiWeb.com

Mon, 28 Sep 2020
Teva Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The Firm - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 1,100
Shares Float (M) 1,090
% Held by Insiders 0.60
% Held by Institutions 54.67
Shares Short (K) 24,500
Shares Short P. Month (K) 24,030

Stock Financials

EPS
EPS Est This Year 4.230
EPS Est Next Year 3.690
Book Value (p.s.) 12.640
Profit Margin 0.02
Operating Margin 18.06
Return on Assets (ttm) 3.3
Return on Equity (ttm)
Qtrly Rev. Growth -7.3
Gross Profit (p.s.) 6.855
Sales Per Share 15.264
EBITDA (p.s.) 4.218
Qtrly Earnings Growth
Operating Cash Flow (M) 1,440
Levered Free Cash Flow (M) 2,310

Stock Valuations

PE Ratio
PEG Ratio 8.66
Price to Book value 0.70
Price to Sales 0.58
Price to Cash Flow 6.74

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2017-12-11
Ex-Dividend Date 2017-11-26
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.